Results 151 to 160 of about 6,976 (185)

8P Genomic variants associated with interstitial lung disease in patients treated with trastuzumab-deruxtecan: Results from the PROCURE project

Rodrigo Sánchez-Bayona, Johny Nicolas, C. Saura Manich, M. Gion Cortes, Juan Miguel Cejalvo, E. Llabrés Valentí, J. Cortés, A. Falcon Gonzalez, Sònia Pernas, A. López de Sá, María Vidal, C. Hinojo González, Tyler J. Curiel, J. Cruz Jurado, María José Echarri, María Isabel Gallegos Sancho, Alberto M. Arenas, Guillermo Villacampa, E.M. Ciruelos, Cristina Rodríguez‐Antona   +19 more
openalex   +2 more sources

Efficacy of Trastuzumab Deruxtecan in HER2-Positive and HER2-Low Metastatic Breast Cancer: A Real-World Retrospective Cohort Study in China

Yuxin Yan, Yizi Jin, Mingxi Lin, Ceng Zeng, Qing Guo, Teng Zhou, D. Li, Jian Zhang   +7 more
openalex   +2 more sources

Trastuzumab Deruxtecan for Human Epidermal Growth Factor Receptor 2-Low Breast Cancer With Cancer-Related Microangiopathic Hemolytic Anemia: A Case Report. [PDF]

Cancer Innov
Li M, Ding M, Hou Y, Duan X, Cheng Y, Xu L.   +5 more
europepmc   +1 more source

Trastuzumab deruxtecan in advanced breast cancer patients with brain metastases or leptomeningeal metastases. [PDF]

Cancer Pathog Ther
Liu J, Quan L, Sang D, Guan X, Dou M, Yue J, Yuan P.   +6 more
europepmc   +1 more source

Trastuzumab deruxtecan in patients with metastatic non-small-cell lung cancer (DESTINY-Lung01): primary results of the HER2-overexpressing cohorts from a single-arm, phase 2 trial

Egbert F. Smit, Enriqueta Felip, Dipesh Uprety, Misako Nagasaka, Kazuhiko Nakagawa, Luis Paz‐Ares, Jose M. Pacheco, Bob T. Li, David Planchard, Christina S. Baik, Yasushi Goto, Haruyasu Murakami, Andreas Saltos, Kaline Pereira, Ayumi Taguchi, Yingkai Cheng, Qi Yan, Wenqin Feng, Zenta Tsuchihashi, Pasi A. Jänne   +19 more
openalex   +2 more sources

Zongertinib, a Novel HER2 Tyrosine Kinase Inhibitor, Maintains an Anticancer Activity for Trastuzumab Deruxtecan-Resistant Cancers Harboring HER2-Overexpression. [PDF]

Int J Mol Sci
Kurosaki T, Suzuki S, Yonesaka K, Kawanaka Y, Takehara T, Teramura T, Sakai K, Nishio K, Hayashi H.   +8 more
europepmc   +1 more source

High expression level of ERBB2 and efficacy of trastuzumab deruxtecan in desmoplastic small round cell tumour: a monocentric case series report

Mehdi Brahmi, Hélène Vanacker, A. Dufresne, V. Isnardi, Margaux Dupont, A. Meurgey, Marie Karanian, P. Meeus, M.-P. Sunyach, Franck Tirode, Jean‐Yves Blay   +10 more
openalex   +1 more source

Trastuzumab Deruxtecan for ERBB2-Mutant Metastatic Non-Small Cell Lung Cancer With or Without Brain Metastases: A Secondary Analysis of Randomized Clinical Trials.

JAMA Netw Open
Jänne PA, Planchard D, Goto K, Smit EF, de Langen AJ, Goto Y, Ninomiya K, Kubo T, Pérol M, Felip E, Hayashi H, Nakagawa K, Shimizu J, Nagasaka M, Pereira K, Taguchi A, Ali A, Karnoub M, Yonemochi R, Leung D, Li BT.   +20 more
europepmc   +1 more source